Edwards Lifesciences Inc. says it will appeal a Delaware judge’s decision not to bar the manufacture and sale of Medtronic Inc.’s CoreValve aortic valve replacement. Medtronic Inc. (NYSE:MDT) managed ...
Almost before the judge's signature was dry on Friday's federal district court preliminary injunction in favor of Edwards Lifesciences Corp. (Irvine, CA) that will block Medtronic from selling its ...
Wall Street and others are continuing to weigh in on Medtronic Inc.’s pending $700 million buy of Irvine device maker CoreValve Inc. Medtronic, which employs some 550 people at its Santa Ana heart ...
Minneapolis-based Medtronic will appeal the Federal District Court of Delaware’s preliminary injuction granted to Irvine, Calif.-based Edwards Lifesciences. The Court issued the preliminary injunction ...
Nontransfemoral implantation, however, was not an independent predictor of mortality and likely reflected the higher risk of the patients treated this way. What's to Be Gleaned From UK TAVI? Speaking ...
Surgical aortic valve replacement (SAVR) devices are widely believed to be considerably more durable than transcatheter aortic valve replacement (TAVR) devices, but five-year data for Medtronic plc’s ...
CoreValve Inc., a French heart valve developer, is switching its headquarters from Paris to Irvine with an eye toward raising money to fund the development of its product. “There is no doubt that ...
Medtronic, Inc. MDT today announced it has received Conformité Européenne (CE) Mark for valve-in-valve (VIV) procedures using the CoreValve® and CoreValve® Evolut(TM) transcatheter aortic valve ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
* Medtronic plc - 23 mm, 26 mm and 29 mm sizes of evolut pro system are available for use in united states Source text for Eikon: Further company coverage: ...
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below: Receive the the latest news, research, and presentations from major meetings ...